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ABSTRACT:Intramuscular gene delivery materials are of great importance in plasmid-based 
gene therapy system, but there is limited information so far on how to design and synthesize 
them. Previous study showed that the peptide dendron-based triblock copolymer with its 
components arranged in areversedbiomembranearchitecture could significantly increase 
intramuscular gene delivery and expression. Herein, we wonder whether copolymers with 
biomembrane-mimicking arrangement may have similar function on intramuscular gene delivery. 
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Meanwhile, it is of great significance to uncover the influence of electric charge and molecular 
structure on the function of the copolymers. To address the issues, amphiphilic triblock 
copolymers arranged in hydrophilic–hydrophobic–hydrophilic structure were constructeddespite 
the paradoxical characteristics and difficulties in synthesizing such hydrophilic but electroneutral 
molecules. The as-prepared two copolymers, dendronG2(ʟ-lysine-OH)-poly propylene 
glycol2k(PPG2k)-dendronG2(ʟ-lysine-OH) (rL2PL2) and  dendronG3(ʟ-lysine-OH)-PPG2k-
dendronG3(ʟ-lysine-OH) (rL3PL3), were in similar structure but had different hydrophilic 
components and surface charges, thus leading to different capabilities in gene delivery and 
expression in skeletal muscle. rL2PL2was more efficient than Pluronic L64 and rL3PL3 when 
mediating luciferase, β-galactosidase and fluorescent protein expressions. Furthermore, rL2PL2-
mediated growth-hormone-releasing hormone expression could significantly induce mouse body 
weight increase in the first 21 days after injection. In addition, both rL2PL2 and rL3PL3 showed 
a good in vivo biosafety in intravenous and intramuscular administration. Altogether, rL2PL2-
mediated gene expression in skeletal muscle exhibited applicable potential for gene therapy. 
Thestudy revealed that the molecular structure and electric charge were critical factors governing 
the function of the copolymersfor intramuscular gene delivery. It can be concluded 
that,combining previous study, bothstructural arrangements either reverse or similar to the 
biomembrane are effective in designing such copolymers. It also provides an innovative way in 
designing and  synthesizing new electroneutralized triblock copolymers which could be used 
safely and efficiently for intramuscular gene delivery.  
KEYWORDS: intramuscular gene transfer, gene expression, electroneutralization, amphiphilic 
copolymer, biomembrane, gene therapy 
INTRODUCTION 
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Production of therapeutic molecules using skeletal myocytes is  an appealing strategy for gene 
therapy due to its safety, low-cost and simplicity.However, it often fails to meet the therapeutic 
needs because the strategy employed for gene delivery is not efficient and, thus, the expression 
level is in general too low.
1-4
 Recently, a large amount of non-viral materials have been 
developed in order to enhance gene delivery efficiency. Cationic polymers and lipids are among 
the most widely-used materials that can be used for in vitro gene delivery, as they can efficiently 
deliver nucleic acids into culture cells.
5-7
 Unfortunately, they usually offered negative results 
when injected intramuscularly  because they have strong interaction with muscle matrix which is 
negatively charged.
5,8-12
 It has been reported that some neutral polymers  including poly(N-vinyl 
pyrrolidone), poly(vinyl alcohol) and Pluronics have the capacity to improve muscular gene 
delivery.
13-19
 We also constructed an electroneutralized triblock copolymer using peptide 
dendron and PEG2k arranged as hydrophobic–hydrophilic–hydrophobic, a reversed biomembrane 
architecture.
20 
It presented much better performance on both reporter and function gene 
expressions in skeletal muscle than that of Pluronic L64, which was reported to givemore 
homogeneous and stable gene expressions than other Pluronic derivatives.
19
The components of 
the copolymer was considered to be arranged in areverse architecture in comparison to that of 
biomembranes, whose bilayer structure usually consists of two outer hydrophilic units and one 
inner hydrophobic part, thus generating a hydrophilic–hydrophobic–hydrophilic 
architecture.Herein, we are interested in a further exploration ofsuch copolymersabout the 
effectivenessof intramuscular gene delivery whiletheir components are reversely arranged, that is, 
a biomembrane-mimicking architecture in hydrophilic–hydrophobic–hydrophilicarrangement. In 
addition, we consider that the amount of electric charges and the architecture of the molecule 
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mightexertdeterminant influence on the intramuscular gene delivery function of the copolymer. 
This point of view also needs further confirmation. 
Pluronics have been considered to have hydrophilic–hydrophobic–hydrophilic architecture 
because their hydrophilic ethylene oxide (EO) and hydrophobic propylene oxide (PO) blocks are 
arranged as EOx–POy–EOx.
21-23
 Although several kinds of Pluronics, such as P85, P105 and L64, 
have attracted much attention for the intramuscular gene transfer ability, our recent study 
revealed that Pluronic L64 was able to generate pores across cell plasma membranes in a both 
time- and concentration-dependent way, which thereby inhibited the endocytosis of transfection 
complex.
24
These effects would consequently compromise the viability of cells and, indeed, the 
biocompatibility of Pluronic L64 would be a concern. One approach to minimizethe adverse 
effects may be the application of more suitable units to construct the triblock copolymers. 
Therefore, we chose peptide dendronsand (poly propylene glycol)2k(PPG2k)as components for 
assembling the new type of copolymers due to their authenticated biocompatibility both in vitro 
and in vivo.
25-27
 Meanwhile, polypeptide dendrons have supplementary advantages like their 
controllable surface functionalization and well-defined structures, which offers marvelous 
convenience for us to assemble copolymers with different molecular structures and surface 
charges using different generation of peptide dendrons.
 20, 28-31
 
In order to assess if the molecular structure and surface charge are critical factors in governing 
the gene delivery properties of these copolymers, two different copolymerswere constructed: (і) 
dendronG2(ʟ-lysine-OH)-PPG2k-dendronG2(ʟ-lysine-OH)(rL2PL2) and (ii) dendronG3(ʟ-lysine-
OH)-PPG2k-dendronG3(ʟ-lysine-OH)(rL3PL3). The two copolymers have the same hydrophilic–
hydrophobic–hydrophilic architecture but different hydrophilic components as well as different 
surface charges. It is well-known thatthe hydrophilic terminal groups will interact with the 
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aqueous phase, thus the synthesisof such electroneutralized copolymers comes to be rather 
difficult.Therefore, it is of meaningful importance to set up a feasible and instructive way to 
synthesize such copolymers at first. 
EXPERIMENTALSECTION 
Materials and Characterization. 
Propargylamine was purchased from Acros Organics (Geel, Belgium). Nα,Nε-di-t-
butyloxycarboryl-ʟ-lysine (Boc-Lys(Boc)-OH), 1-hydroxybenzotriazole (HOBT), N,N-
Diisopropylethylamine(DIPEA), N,N,N',N'-tetramethyl-O-(1H-benzotriazol-1-
yl)uroniumhexaﬂuorophosphate (HBTU) and triﬂuoroacetic acid (TFA) were from Gil Biochem. 
Co. Ltd.  (Shanghai, China). Pluronic L64 (EO13PO30EO13; Mw = 2900), Sodium ascorbate, 
sodium azide (NaN3), polyetheramine (NH2-PPG-NH2, Mw≈2000), and other chemicals were 
from Sigma-Aldrich (St Louis, MO, USA). G2 (G2-4NHBoc-alkynyl) was synthesized 
according to previous protocol.
20
 
Characterization and structure confirmation of the intermediates and products were measured 
by  electrospray ionization time-of-ﬂight mass spectrometry (ESI-TOF MS, Waters Q-TOF 
Premier),
 1
HNMR (400 MHz Bruker Advanced 600 Spectrometer) and matrix assisted laser 
desorption ionization time-of-ﬂight (MALDI-TOF, Autoﬂex MALDI-TOF/TOF) mass 
spectrometry. Zeta potentials of rL2PL2, rL3PL3 and L64 dissolved in deionized water were 
measured by a Malvern Zetasizer Nano ZS (Malvern Instruments). 
Plasmids of pSC-LacZ, pSC-Luc, pSC-E2 and pSC-GHRH, which carry genes of β-ᴅ-
galactosidase, luciferase, far-red fluorescent protein and growth-hormone-releasing hormone 
respectively, were constructed in our laboratory and prepared as described.
32
 
Synthesis of G3 (G3-8NHBoc-alkynyl). 
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Under a nitrogen atmosphere, the peptide G2 (4.0 g, 476 mmol) was dissolved in anhydrous 
dichloromethane (15 mL), cooled to 0 °C and trifluoroacetic acid (15 mL, 197 mmol) was added. 
After a 8-hour stirring at room temperature, trifluoroacetic acid and solvents were cleared by 
rotary steam. The collected solid was dissolved in 15 mL anhydrous DMF and the mixture of 
HOBT (6.2 g, 46 mmol), Boc-Lys (Boc)-OH (12.6 g, 364 mmol), anhydrous DMF (10 mL) and 
HBTU (12.0 g, 36 mmol) were added in. The as-prepared solution was cooled down to 0 °C, and 
139 mmol DIPEA (23.0 mL) was added in under nitrogen. After a 72-hour stirring at room 
temperature, the mixture was diluted with ethyl acetate and washed by 3×15 mL saturated 
sodium bicarbonate solution, 3×15 mL 1M hydrochloric acid and 3×15 mL saturated sodium 
chloride solution, respectively. The organic layer was dried with anhydrous magnesium sulfate, 
followed by concentrating, recrystallizing and vacuum drying, generating a white solid. 
1
H NMR 
(400 MHz, CDCl3) δ: 4.45−4.33 (d, 7H), 4.04 (s, 2H), 3.32−2.91 (m, 14H), 2.20 (s, 1H), 
1.87−1.75 (m, 28H), 1.46−1.43 (m, 86H). 
Synthesis of 2-Azidoethanol (AE). 
3.5 g sodium azide  was dissolved in 15 mL water, and then 2.8 mL 2-Chloroethanol was 
slowly added at room temperature. After stirring for 24 h at 80 
o
C, the mixture was cooled down 
to room temperature, saturated with sodium chloride and extracted with 3×10 mL 
dichloromethane. The organic layer was dried using anhydrous sodium sulfate and the solvent 
was removed under reduced pressure to obtain the colorless liquid AE (2.8 g, 74%).
331
H NMR 
(400 MHz, CDCl3) δ: 3.81–3.75 (m, 2H), 3.48–3.41 (m, 2H), 2.42 (dd, 1H). 
Synthesis of 2-Azidoethyl 1H-imidazole-1-carboxylate (AE-CDI). 
AE-CDI was synthesized from the obtained AE. Brieﬂy, a dry round-bottomed ﬂask was 
charged with 4.8 g carbonyldiimidazole (CDI) and 40 mL dichloromethane, yielding a 
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suspension. At room temperature, 1.9 g AE with 20 mL dichloromethane was added dropwise 
and vigorously stirred to generate a clear solution, which was then washed with water for three 
times. After drying with anhydrous magnesium sulfate, the organic layer was ﬁltered and 
evaporated, yielding 3.5 g colorless liquid AE-CDI. 
1
H NMR (400 MHz, CDCl3) δ: 8.17 (s, 1H), 
7.45 (t, 1H), 7.10–7.06 (m, 1H), 4.60–4.55 (m, 2H), 3.68–3.63 (m, 2H). 
Synthesis of Azido-terminated PPG (N3-PPG-N3). 
In a dry ﬂask with round-bottom, 3.4 g AE-CDI was dissolved in 20 mL dichloromethane and 
dropped slowly (about 1.5 h) into a solution of NH2-PPG-NH2 (2000 Da, 16.7 g, 8 mmol) in 25 
mL dichloromethane at room temperature. Next, the reaction mixture was heated to 35 
o
C using 
an oil bath until no primary amine groups were detected in the solution (detection by 0.5% 
ninhydrin solution). After removal of dichloromethane under reduced pressure by evaporation, a 
yellow liquid was obtained and dissolved in 30 mL chloroform, followed with washing using 
3×15 mL deionized water. The organic layer was dried with anhydrous sodium sulfate and the 
solvent was removed under reduced pressure to obtain N3-PPG-N3. The product, a light yellow 
liquid was dissolved in CDCl3 and characterized by 
1
H NMR. No unreacted AE-CDI was 
detected. The relative molecular weight (Mn) was calculated to be 2170 dalton or g/mol, as 
analyzed later. 
1
H NMR (400 MHz, CDCl3) δ: 4.2(s, 4H), 3.6-3.7 (m, 8H), 3.4 (m, 89H), 1.14(m, 
93H). 
Synthesis of G2-terminated PPG (G2-PPG-G2) and G3-terminated PPG (G3-PPG-G3). 
The peptide G2 (0.6 g, 0.7 mmol) or G3 (1.6 g, 0.9 mmol) and the azide N3-PPG-N3 (0.7 g, 
0.3 mmol) were dissolved in 44 mL of anhydrous N,N-dimethyl-formamide (DMF) and 14 mL 
of water to form a solution mixture. Then, 0.2 equiv CuSO4·5H2O and 1.0 equiv sodium 
ascorbate were added to the solution,
34
 stirred for 36 h (G2) or 48 h (G3) at room temperature 
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under N2. Finally, the rubber septum was removed in about 2 h under stirring, generating 
oxidation of Cu (I) catalyst into Cu (II). After the removal of the solvents, the crude product was 
dissolved in chloroform (30 mL) and washed with deionized water (3×15 mL), followed by 
drying with anhydrous sodium sulfate. A yellow solid was obtained after the solvent was 
removed under reduced pressure. The excess G2 or G3 was removed by dialysis against 
chloroform/methanol (3:1 or 2:1, V/V) in a cellulose ester membrane (Spectra/Por Biotech 
MWCO 2000; Spectrum Laboratories) for 2 days and evaporated to obtain a ﬂuffy, yellow solid. 
G2: 
1
H NMR (400 MHz, CDCl3) δ: 7.63 (s, 2H), 4.83 (s, 4H), 4.61–4.04 (m, 14H), 3.94 (s, 2H), 
3.79–3.21 (m, 97H), 3.01 (s, 12H), 1.79–1.53 (m, 12H), 1.49–1.18 (m, 102H), 1.07 (dd, 93H).G3: 
1
H NMR (400 MHz, CDCl3) δ: 7.66 (s, 2H), 5.01−4.82 (m, 4H), 4.55−4.27 (m, 22H), 3.95 (s, 
2H), 3.83–3.12 (m, 97H), 3.02 (s, 28H), 1.66 (s, 28H), 1.52–1.25 (m, 203H), 1.21–0.90 (m, 93H). 
Synthesis of Isopropylidene-2,2-bis(oxymethyl)propionic Acid (DHPA). 
DHPA was synthesized according to previous procedure.
35
 Briefly, 2, 2-bis (hydroxymethyl) 
propionic acid (13.4 g, 0.1 mol) was dissolved in 90 mL of anhydrous acetone at room 
temperature. Then 2,2-dimethoxypropane (18.4 mL, 0.2 mol) and p-toluenesulfonic acid (1.7 g, 
10mmol) were added to the solution. After stirring for 6 h, the catalyst in the reaction mixture 
was neutralized by adding 5 mL NH4OH/EtOH solution (1:1, V/V) and the solvent was 
evaporated at room temperature. The product was dissolved in 60 mL CH2Cl2 and washed with 
deionized water (3×15 mL). The organic layer was dried with anhydrous sodium sulfate and the 
solvent was removed under reduced pressure to obtain the white solid DHPA (16.5 g, 94%). 
1
H 
NMR (400 MHz, CDCl3) δ: 4.18 (s, 1H), 4.15 (s, 1H), 3.72 (s, 1H), 3.69 (s, 1H), 1.46 (s, 3H), 
1.44–1.42 (m, 3H), 1.20 (s, 3H). 
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Synthesis of N-hydroxysuccinimideIsopropylidene-2,2-bis(oxymethyl)propionate (DHPA-
NHS). 
DHPA (13.1 g, 75mmol) and N-hydroxysuccinimide (NHS) (9.2 g, 80mmol) were dissolved 
in 200 mL of dichloromethane at room temperature. Subsequently, N,N'-dicyclohexylcarbodi-
imide (DCC) (16.5 g, 80mmol) in 60 mL dichloromethane was slowly added dropwise to the 
solution at 0 
o
C around 1 h. The reaction mixture was then stirred for 24 h at room temperature. 
The white precipitate of dicyclohexylurea (DCU) was removed by suction filtration, and the 
ﬁltrate was concentrated under reduced pressure. The waxy solid was recrystallized from ethyl 
acetate and dried to obtain DHPA-NHS as a white crystals (17.5 g, 86%). 
1
H NMR (400 MHz, 
DMSO-d6) δ: 4.09 (d, 2H), 3.79 (d, 2H), 2.81 (s, 4H), 1.40 (s, 3H), 1.28 (s, 3H), 1.21 (s, 
3H).Good agreement was found with the literature.
36
 
Synthesis of rL2PL2 and rL3PL3. 
G2-PPG-G2 (0.65 g, 0.18 mmol) or G3-PPG-G3 (1.0 g, 0.2 mmol)was dissolved in 15 mL or 
20 mLanhydrous trifluoroacetic acid/dichloromethane (1:1, V/V) and the solution was stirred for 
4 h or 8 h respectively under N2 at room temperature. After the removal of the solven by rotary 
evaporation, the precipitates were ultrasonic washed by saturated sodium carbonate solution and 
then collected by suction filtration. The sample was dried for 12 h under high vacuum (with 
phosphorus pentoxide). The deprotected product with 8 (G2-PPG-G2) or 16 (G3-PPG-
G3)primary amine groups was dissolved in 20 mL anhydrous dichloromethane/Et3N (1:1, V/V) 
at room temperature.DHPA-NHS (0.8 g, 3 mmol for G2-PPG-G2; or 1.6 g, 6 mmol for G3-
PPG-G3) was added to the solution and then stirred for 24 h or 36 h at room temperature. The 
solvents were removed after work-up by rotary evaporation. The product was puriﬁed by dialysis 
against chloroform/methanol (1:1, V/V) in a cellulose ester membrane (Spectra/Por Biotech 
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MWCO 2000) for 48 h and evaporated to obtain a pale yellow solid. This product, DHPA-
terminated G2-PPG-G2 or G3-PPG-G3, was dissolved in 60 or 90 mL of methanol and 
concentrated sulfuric acid (21 or 25 drops) was added. The solution was stirred at room 
temperature for 24 h and then neutralized with NH4OH/EtOH solution. By filtration, insoluble 
NH4SO4 was removed and the filtrate was condensed. The rL2PL2 or rL3PL3 residue was 
dissolved in 20 or 15 mL deionized water and transferred into a Spectra/Por Biotech MWCO 
2000 cellulose ester membrane for 48 or 72 h. The retained solution was filtered through a 1-μm 
Acrodisc and lyophilized to a pale yellow liquid. rL2PL2: 
1
H NMR (400 MHz, DMSO-d6) δ: 
7.62 (s, 2H), 4.55 (s, 4H), 4.29 (d, 6H), 4.20 (s, 4H), 3.84 (s, 2H), 3.55–3.47 (m, 97H), 3.47–3.25 
(m, 32H), 3.01 (d, 12H), 1.57 (d, 12H), 1.36 (s, 12H), 1.22 (d, 12H), 1.12–0.90 (m, 
121H).rL3PL3: 
1
H NMR (400 MHz, DMSO-d6) δ: 7.42 (s, 2H), 4.55 (s, 4H), 4.29−4.19 (m, 
22H), 3.84 (s, 2H), 3.85−3.47 (m, 97H), 3.47−3.30 (m, 64H), 3.00 (s, 28H), 1.77−1.11 (m, 
112H), 1.10−0.91(m, 147H). 
Micelle Characterization 
The formation of micellar structures were studiedby steady-state fluorescence of pyrene. The 
fluorescence emission spectra were scanned by a Spectrophotometer (F-7000 FL, Hitachi) upon 
excitation at 390 nm. 
DNA Retardation Assay. 
 pDNA (1 µg) and different amounts of rL2PL2 or rL3PL3 were diluted respectively in 10μL 
of 0.9% saline, incubated for 30 min at room temperature after mixing. The mixtures were then 
run on 1% (w/v) agarose gel at 80 V for 1 h.The DNA bands were photographed and visualized 
in the imager (Bio-Rad ChemiDoc XRS+, USA) after ethidium bromide (EB) staining. 
In Vivo Gene Delivery Assay. 
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Animals were handled and operated as previously described with some modifications.
20,32
 
Briefly, pSC-GHRH (50 μg in 80 μL solution) instead of pSC-GH was used to evaluate the 
mouse growth rate. Mice were sacrificed 4 days after administration and the TA muscles were 
separated and processed for different experimental tests. In vivo reporter gene assays were 
operated according to the manufacturers’ protocols of different Kits, such as In Situ β-
Galactosidase Staining Kit (Beyotime, Shanghai, China) for the β-galactosidase activity assay, 
the Reporter Assay Kit (Promega, Madison, WI, USA) and BCA Protein Assay Kit (Pierce, 
Rockford, IL, USA) for luciferase activity analysis. The expression of  the fluorescent protein 
E2-Crimson was detected on the days 7 and 14. 
Histological Section Analysis. 
Histological analysis of the TA muscles were performed 24 h after intramuscular injection of 
40 μL  0.9% saline or 0.005% rL2PL2 or 0.02% rL3PL3. The separated TA muscles were fixed 
for 24 h in 4% fresh formaldehyde solution, dehydrated with gradient concentrations of ethanol, 
embedded in paraffin and then sliced into 10-μm sections in cross and longitudinal directions. 
The sections were immersed for 3 min in hematoxylin, dipped in eosin and mounted in mineral 
oil under a coverslip. Figures of the sections were taken with a microscope (Leica DMI 4000B; 
Wetzlar, Germany) for histopathological analysis. 
Serum Biochemical Test. 
Mice were injected with 200 μL  of saline or 0.005% rL2PL2 or 0.02% rL3PL3 through tail 
veins. The blood was collected for sera separation on day 4 by centrifugation at 3000 rpm for 10 
min at 4°C. The sera were biochemically analyzed using the 7020 Automatic Analyzer (Hitachi, 
Japan). 
Statistical Analysis. 
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Data were provided as mean ± standard deviation (SD.). Comparisons were analyzed by t−test 
among groups. The value of P < 0.05 was considered to be signiﬁcantly different, while P < 0.01 
was highly significant. 
RESULTS AND DISCUSSION 
Molecular Design, Synthesis and Characterization of rL2PL2 andrL3PL3. 
Some key characteristics of Pluronics might exert influence on their local gene transfer 
capability, such as the polymerization level of EO and PO units,  hydrophilic/lipophilic balance 
(HLB), structure of the whole molecule, critical micelle temperature (CMT) and critical micelle 
concentration (CMC).
22, 23
 However, there is not any reliable theory relevant to the molecular 
design of the electroneutralized amphiphilic copolymers. It is also difficult to predict the 
intramuscular gene delivery capability of a synthesized molecule. Theoretically, if the terminal 
groups in a molecule are hydrophilic, there shouldbe an interactionbetween them and water 
phase, which will make the molecule positivelycharged. So it is difficult to construct an 
uncharged molecule with hydrophilic terminal groups. Herein, thefirstchallenge in synthesizing 
such amphiphilic triblock copolymers is to neutralize their electric charges. With trials and errors, 
we finally synthesized rL2PL2and rL3PL3copolymers.In these molecules, NH2-terminated PPG 
was used as the middlehydrophobic unit to connect both ends ofhydroxylated hydrophilic 
dendron G2 or G3. The whole structure wassymmetrical and presented with a “butterfly” 
architecture. 
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Scheme 1Synthetic route ofG2-PPG-G2 andG3-PPG-G3 by efficient and fast azide-alkyne 
click reaction. 
The triblock copolymers were firstly synthesized  according to the liquid-phase peptide 
synthesis method as shown in Scheme 1. G2 was synthesized in our previous work.
20
 Here, the 
third-generation of ʟ-lysine G3 was synthesized from G2. In order to connect PPG with G2 or 
G3 through organic azide and alkyne click chemistry, NH2-ended PPG should be turned into N3-
ended PPG firstly, as  shown in Scheme 1. In particular, N,N-carbonyldiimidazole (CDI) was an 
potent activating agent for the connection of 2-azidoethanol and NH2-PPG-NH2. The amidation 
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by CDI showed advantages of mild reactioncondition and near-quantitative yield.
37, 38
 As showed 
in scheme 1, G2-PPG-G2 and G3-PPG-G3with designedchemical structure and relative 
molecular weight were obtained by high-efficiency click reaction of different generation of ʟ-
lysine with activealkinyl groupinN3-PPG-N3. 
The structure and purity of G3 was confirmed in Figure S1. Figure 1 (A~H) showed 
1
H NMR 
spectra and MALDI-TOF-mass spectra of N3-PPG-N3, G2-PPG-G2 and G3-PPG-G3. The 
bifunctional PPG with two amine terminal groups (NH2-PPG-NH2) is commercially available 
and also named aspoly(propyleneglycol) bis(2-aminopropyl ether). In general, PPG 
showedhydrophobicity when its molecular weight is lower than 740 g/mol.
39
 Compared with N3-
PEG-N3 in our previous work,
20
 PPG causeddifferent synthetic methods (Scheme 1). Particularly, 
NH2-PPG-NH2was used as the initial raw material for N3-PPG-N3 preparation to avoid the 
interference with terminal groups, such as monohydroxy PPG.
40
 AE was simply translated into 
AE-CDI, and CDI was obviously demonstrated to be linked to AE due to the appearance of 
chemical shifts of number c, d and e of hydrogen (Figure 1A and S2). 
1
H NMR analysis of the 
acquired product (Figure 1B) showed that the starting compound AE-CDI was absent (the NMR 
spectra of AE-CDI vs NH2-PPG-NH2 in Figure 1A and C, respectively). The azide-
functionalization ofPPG wasconfirmedby the absence of the peaks at low field (higher than 7.0 
ppm) for N3-PPG-N3 as well as the disappearance of the protons of primary amine and chemical 
shift of protons neighbored to amide bonds. The intermediate of N3-PPG-N3 was then clicked 
with the propargyl focal point G2 or G3-typed dendrons to produce G2-PPG-G2 or G3-PPG-
G3 by Cu
Ⅰ
˗catalyzed cycloaddition (CuAAC) (Scheme 1). The signal of new proton at about 
7.54 ppm, the typical peak of methine in the triazole ring, appeared within the 
1
H NMR spectra 
of G2-PPG-G2 (Figure 1D or G3-PPG-G3 in Figure S3), whereas the original peak of azide-
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methylene (CH2−N3) for N3-PPG-N3 completely disappeared. The results demonstrated that the 
intermediate of N3-PPG-N3 was quantitatively transformed into G2-PPG-G2 or G3-PPG-G3. 
 
Figure 1.Characterization of the intermediates.
 1
H NMR spectra of AE-CDI (A), N3-PPG-N3 (B), 
NH2-PPG-NH2 (C) and G2-PPG-G2 (D). MALDI-TOF mass spectra of G2-PPG-G2 (E) and 
G3-PPG-G3 (H).Partial enlarged details of G2-PPG-G2 with relative molecular weights around 
m/z 1813.4 (F) and m/z 3735.9 (G). 
 
Furthermore, the mass spectrometry MALDI-TOF analysis of G2-PPG-G2 showed an almost 
symmetrical main distribution of peaks centered around m/z 3735.9 and a series of peakslower in 
mass corresponding to a small amount of schizolytic compound of G2-PPG-G2 (Figure 1E~G). 
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Peaks centered on m/z 1813.4 were assigned toN3-PPG-N3. Peak of m/z 2706.0 was assigned to 
the single substitution product of G2. The repetitive unit of PG with m/z 58 was clearly 
presented in the mass spectra (Figure 1F and 1G). In Figure 1H, the mass spectra of G3-PPG-G3 
wereshownto match wellwith the theoretical molecular weights. 
 
Scheme 2 Structures and Synthesis of rL2PL2 and rL3PL3. 
 
The last step was thehydrophilization of G2-PPG-G2andG3-PPG-G3, as shown in Scheme 2.  
In our previous studies, peptidedendrimers were synthesized using azide-alkyne click 
reactionfollowed by the deprotection of the protecting groups (Boc groups),
20
so as to generatethe 
ﬁnal water-soluble dendrimers due to the hydrophilic amine and their hydrochloride or 
trifluoroacetic acid salt.
29, 41
 One major challengetodevelop effective intramuscular gene delivery 
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materials is to make the materialselectroneutralized or withnon-easily ionized terminal group, 
andalcoholic hydroxyl is one of the very few choices.
35, 42
 Here, the novel cyclic carbonate 
monomer, DHPA-NHS, was easily prepared by a two-step reaction starting from 2,2-
bis(hydroxymethyl)propionic acid (Scheme 2). The 2,2-dimethyloxypropane was selected to 
protect the diolagainst the inter- and intramolecular side reactions of 2,2-
bis(hydroxymethyl)propionic acid. In addition, NHS has the ability to protect the carboxylic 
group due to the formed active ester, which can react with primary amines under mild conditions 
in the following steps. The acetonide-protecting group can be removed easily at room 
temperature by stirring the methanol solution of DHPA-capped polymer with Dowex 50W cation 
resin, or directly adding a few drops ofconcentratedsulfuric acid.
35, 42, 43
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Figure 2.Characterization of rL2PL2 and rL3PL3.
1
H NMR spectra of rL2PL2 (A) and 
hydrophilization of G2-PPG-G2 (B).MALDI-TOF mass spectra of rL2PL2 (C) and rL3PL3 (D). 
 
The chemical structure of DHPA and DHPA-NHS were conﬁrmed by 1H NMR spectroscopy 
(Figure S5). Each synthesis step of rL2PL2or rL3PL3 was detected by the 
1
H NMR, ninhydrin 
test and MALDI-TOF-MS. It was confirmed that the syntheses of rL2PL2 and rL3PL3were 
completed (Figure 2A and Figure S6). Linkage of DHPA to Boc-deprotected G2-PPG-G2 was 
obviouslydemonstrated by the disappearance of chemical shifts of Boc-methyl-protons(Figure 
2B). Each theoretically predicted peak of the chemical shifts of rL2PL2 and rL3PL3 in DMSO-
d6solutioncould be found,which meantthat the designed polymers were obtained.And even the 
MALDI-TOF-mass spectra of rL2PL2 and rL3PL3have proved to be in accordance with the 
designed (Figure 2C and 2D).The results confirmed that the detected value of the molecular 
weight well matched the theoretical one. 
Due to the amphiphilicity of the two copolymers, the onset of the formation of rL2PL2 or 
rL3PL3 micelles was measured using pyrene as a hydrophobic probe. The intensity ratios of the 
pyrene excitation bands at338 and 334 nm(I338/I334) to the logarithms of the concentrations of 
rL2PL2 orrL3PL3were shown in Figure S7. The CMC of rL2PL2 orrL3PL3was0.056 mg/mL or 
0.251 mg/mL, obtained from the intersection of the two straight lines. 
 
DNA Retardation Assay and Zeta Potential. 
Cationic gene delivery materials usually decreased the intramuscular gene delivery and 
expression level, whereas electroneutral materials increased the efficiency. Therefore, electric 
charges of rL2PL2and rL3PL3 molecules should be detected at first. DNA retardation assay has 
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been widely used for the detection of the interaction between molecules and DNAs, because 
DNAs are negatively charged and may interact with positively charged molecules. Upon 
combination, either in chemical or physical manner, DNA migration will be retarded in agarose 
gelelectrophoresis.
44
 Theoretically, when alcoholic hydroxyl groups are arranged as the ending 
groups, there would be an interaction between the copolymer and the aqueous phase, resulting in 
the positively charged copolymer. Therefore, the charge of the copolymer is uncertain. It 
depends on the number of hydroxyl groups in the copolymer. When the number is small enough, 
the interaction will be extremely weak and can be ignored. However, if there are too many 
hydroxyl groups in one molecule, the interaction will be superimposed to be strong. Here we can 
see that in the agarose gel, the DNA bands were completely identical in both migration and 
strength even at the highest concentration, indicating that neither rL2PL2 nor rL3PL3 bind with 
DNA molecules (Figure3A). Zeta potentials were further tested to quantitatively analyze the 
surface charges of the copolymers. The charge of rL2PL2was 3.39 mV while rL3PL3, 8.54 mV 
(Figure3B). As the charges were not strong enough to compress DNAs at each concentration 
(Figure3A), the two copolymers might be considered to be approximately electroneutralized. 
 
Figure 3. DNA retardation assay (A) and Zeta potentials (B). Lane 1: naked pDNA; Lane 2-17: 
the copolymer/pDNA mixtures with increasing mass ratios (m/m%). 
 
In Vivo Biocompatibility Assays of rL2PL2 and rL3PL3. 
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To evaluatethe biocompatibility of the copolymers, we sectioned the injected TA muscles 
crossly and longitudinally for histopathological analysis. The sections didn’t show any 
pathological changes including inflammatory reaction and necrosis focus. In addition, there was 
no visible difference among 0.9% saline (Figure 4, A& D), 0.005% rL2PL2 (Figure 4, B& E) 
and 0.02% rL3PL3 (Figure 4, C & F) groups. These results clearly indicated that rL2PL2 and 
rL3PL3 could be used for local intramuscular administration safely. Furthermore, the serum 
biochemical tests were used to evaluate the biosafety of rL2PL2 and rL3PL3 when 200 μL of 
0.005% rL2PL2 or 0.02% rL3PL3 solution was intravenously injected into a mouse, respectively. 
The widely accepted clinical indexes to value liver and renal function and blood glucose were 
examined. The data showed no obvious difference among 0.9% saline, 0.005% rL2PL2 and 0.02% 
rL3PL3 treatments (Table 1). It further confirmed that rL2PL2 and rL3PL3copolymers had good 
biocompatibility. 
 
Figure 4. Representative HE-stained tissue sections in TA muscles injected with saline (A&D), 
0.005% rL2PL2 (B&E) and 0.02% rL3PL3 (C&F). A, B & C: cross sections; D, E & F: 
longitudinal sections. Scale bar = 100 μm. 
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Table 1. Serum biochemical tests of mice injected with saline, rL2PL2 and rL3PL3 
Items Saline rL2PL2 rL3PL3 
Liver function 
ALT (U/L) 51.50±14.79 44.25±6.23 51.25±10.04 
AST (U/L) 107.75±24.39 107.75 ±21.75 111.00±19.91 
ALP (U/L) 236.25±24.58 237.00 ±22.45 258.25±19.09 
TP (g/L) 55.48±2.71 54.58±2.01 54.75±3.04 
ALB (g/L) 27.03±1.32 26.40±0.91 26.83±1.61 
Renal function BUN (mmol/L) 18.63±1.25 16.28±0.88 17.38±2.66 
Blood glucose GLU (mmol/L) 9.34±1.99 10.27±0.57 9.84±1.59 
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, 
alkaline phosphatase; TP, total protein; ALB, albumin; BUN, blood urea nitrogen; GLU, 
glucose. Data were presented as mean ± SD (n = 6/group). 
 
Reporter Gene Delivery and Expression viaIntramuscular Injection. 
Herein, rL2PL2-andrL3PL3-mediated reporter gene expressions through intramuscular 
administration were tested both qualitatively and quantitatively. The expression of β-
galactosidase (LacZ) in mice TA muscles could offere a visible and fast evaluation of the 
transgene expression level as well as its spatial distribution. In this study, 0.1% L64 was used as 
the positive control, as its local gene transfer activity was similar to and also more stable than 
that of the other Pluronics (0.05% P104, 0.05% P123, 0.1% P105 and 0.05% F127). As shown in 
Figure5A, L64(0.1%)/pDNA and most of rL2PL2/pDNA mixtures with different mass ratios 
from 0.001% to 0.05%as well as some rL3PL3/pDNA mixtures showed higher LacZ expression 
level than that of the naked pDNA group, which was evident from the color and distribution 
patterns shown on the surfaces of stained muscles. For further analysis, luciferase expression 
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level indicated by its activity was examined and gave quantitative results in different groups 
(Figure5B). In rL2PL2/pDNA groups, the luciferase activitywas not as good as pDNA when the 
concentration of rL2PL2was 0.001%.However, the activitysharply rosewhen the mass ratio of 
rL2PL2 was elevated. It reached the peak at 0.005% and thengradually decreased along with the 
increase ofrL2PL2 concentration from 0.01% to 0.05%. The luciferase activity of the 0.05% 
group was dropped to a similar level as that in 0.001% and pDNA groups. Quantitatively, 
0.005% rL2PL2 increased transgene expression level up to 15-fold compared to that of naked 
DNA and 2.7-fold as for 0.1% L64. For rL3PL3, although the luciferase expression was 
improved at the concentration of 0.02%,the results were significantly fluctuated, indicating that 
rL3PL3-mediated transgene expression was 
unstable. 
 
 
Figure 5.In vivo transgene expression assays. n = 6/group. (A). Representative figures of β-
galactosidase expression in mice TA muscles. a) Naked pDNA; b) L64(0.1%)/pDNA; c-g) 
rL2PL2/pDNA mixtures with various mass ratios (c: 0.001%; d: 0.005%; e: 0.01%; f: 0.02%; g: 
0.05%); h-l)rL3PL3/pDNA mixtures with various mass ratios (h: 0.001%; i: 0.005%; j: 0.01%; k: 
0.02%; l: 0.05%). (B) Luciferase activity assay in mice TA muscles. a) Naked pDNA; b) 
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L64(0.1%)/pDNA; c-g) rL2PL2/pDNA mixtures with various mass ratios (c: 0.001%; d: 0.005%; 
e: 0.01%; f: 0.02%; g: 0.05%); h-l) rL3PL3/pDNA mixtures with various mass ratios (h: 0.001%; 
i: 0.005%; j: 0.01%; k: 0.02%; l: 0.05%). **: P < 0.01 vs group a; ##: P < 0.01 vs group b. 
Expression of transgenes encoding visible products in living animal has been considered as 
more convenient method in the evaluation of expression intensity and duration. To address this 
issue, the far-red fluorescent protein E2-Crimson expressed by the plasmid pSC-E2 was detected 
in a certain period of time using an in vivo imaging system to monitor the transgene expression 
level in TA muscles. After a single injection, expression levels  of the E2-Crimson were 
examined at Day 7 and 14 (Figure 6). By comparing the intensity and stability of the fluorescent 
signals in the 4 groups, the tendency about their effects  canbe summarized as follow: 
pDNA/rL2PL2(0.005%) > pDNA/L64(0.1%) > pDNA/rL3PL3(0.02%) > naked DNA. Signals in 
pDNA/rL2PL2(0.005%) group were strong and lasted for at least 14 days without visible 
attenuation. It indicated the potential of rL2PL2 as an efficient material capable of delivering 
gene (pDNA) into skeletal muscle for therapeutic application. 
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Figure 6.In vivo imaging of the far-red fluorescent protein expression at Day 7 (left) and 14 
(right) after administration. pDNA: naked pDNA; L64: pDNA/L64(0.1%); rL2PL2: 
pDNA/rL2PL2(0.005%); rL3PL3: pDNA/rL3PL3(0.02%). 
 
Functional Gene Expression Assay. 
It has been a promising strategy to express therapeutic molecules for the treatment of many 
diseases by using intramuscular administration of pDNA, even though most of the trials have 
been focused only on the reporter genes so far. When it is for therapeutic purposes, the absolute 
amount of the expressed molecules have to reach a high level that can meet the required 
concentration either in a local tissue or the circulatory system in order to keep their therapeutic 
functions.
45,46
 Gene delivery material has to be given prime attention, considering the role it 
plays in this process as one of the most important determinants. As the expression of functional 
gene has been mostly evaluated by its biological or therapeutic effects, and unlike reporter gene 
whose expression could be based on simply data comparison, it would be more convincible if we 
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use functional gene to investigate the applicable potential of these materials. Growth-hormone-
releasing hormone (GHRH) was used as the functional gene in this study as it has a significant 
physiological effect on the progress of mouse growth. A single injection of 50 μg plasmid pSC-
GHRH had been administrated, and then the body weights of mice in different groups were 
recorded. Compared to mice inthe saline group, which were considered as natural growth, mice 
from the pSC-GHRH/rL2PL2(0.005%) group showed an accelerated growth rate for 21 days 
after the intramuscular injection (Figure 7). When compared with the naked DNA and 
pDNA/L64(0.1%) groups, the pDNA/rL2PL2treatment also  contributed a significant increase to 
mouse growth. But such an increase was not obtained in the pDNA/rL3PL3(0.02%)group.This 
meantthe expression amount of GHRHupon a pDNA/rL2PL2(0.005%)injectionwas high enough 
for physiologicaleffects. It is also conceivable that some therapeutic effects might be acquired if 
the suitable therapeutic gene(s) instead of GHRH had beenadministrated here. 
 
Figure 7. Average animal body weights after the injection of saline, naked pDNA, 
pDNA/L64(0.1%), pDNA/rL2PL2(0.005%) and pDNA/rL3PL3(0.02%), respectively. n = 
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6/group. 50 μgpSC-GHRH plasmid per mouse. *: P < 0.05 vspDNA; #: P < 0.05 
vspDNA/L64(0.1%). 
From the acquired data, it can be found that the different capabilities of rL2PL2and rL3PL3on 
both reporterand functional gene expressions mainly derive from their different surface charges 
(3.39 mVvs8.54 mV) and molecular architectures. Firstly, the higher surface charge 
ofrL3PL3(8.54 mV)will result in easier and stronger interactions between rL3PL3 and negatively 
charged molecules in the muscles.These interactionsmay consequently interfere and weaken the 
interaction of the copolymer with cell membranes.We have revealed that Pluronic L64 could 
exert a membrane-disturbingeffecton and thus facilitate the gene transfer through the cell 
membrane,
24,32
 so we would like to consider that rL2PL2and rL3PL3 may have ananalogous 
mechanism because they share the same amphiphilic structure with L64 and 
biomembranes.Additional perfect examples about the influence of surface charge on gene 
delivery were previous findings that intramuscular gene delivery and expression trials were 
usually greatly depressed by cationic polymers and lipids.
7
Secondly, the different capabilities of 
rL2PL2and rL3PL3may also derive from their different molecular architectures. As the optimal 
concentrations of the two copolymers were below their CMCs, theywereunimersinstead of 
micelles upon injection into the muscles.The initial parts of the copolymer unimers interacting 
with cell membranes should be their outer hydrophilic parts, that is, G3 for rL3PL3orG2 
forrL2PL2. Because the dendron G3 has a more complicated structure than G2, we might image 
that it should be more difficult for rL3PL3 to disturb and even penetrate cell membranes. That 
means the architecture ofrL3PL3may be beyond the fitness for biomembranes whereas 
rL2PL2has a more suitable one. In addition, rL2PL2had better performance than L64. This may 
be mainly due to their difference in the outer hydrophilic units. The dendron G2 wings in 
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rL2PL2 are bigger than the linear PEOs in L64, which may give an explanation of why rL2PL2 
could have more active and dynamical function on the cell membrane than PEOs. These 
potential mechanisms are still under investigation. 
CONCLUSIONS 
Neutral polymers had much better performance than cationic polymers and lipids in 
intramuscular gene delivery and expression trials. In this study, two amphiphilic triblock 
copolymers rL2PL2 and rL3PL3 were designed, synthesized and electroneutralized. Although 
they shared the same hydrophilic–hydrophobic–hydrophilic structure with Pluronic L64, the 
three copolymers had different intramuscular gene delivery capabilities. rL2PL2had best 
performance in both reporter and functional gene delivery and expression assays among the three 
copolymers. In comparison, it seems that rL2PL2 possessed more suitableparameters for 
intramuscular gene delivery, such as the surface charge, molecular weight and structure of the 
outer hydrophilic unit, and the whole architecture of the copolymer. In addition, the dendritic 
peptides that made rL2PL2 and rL3PL3 have good biocompatibility in local injection and 
systemic administration. The most exciting result was that functional gene expression mediated 
by rL2PL2 had exhibited significant biological effects on mice, which indicates an applicable 
potential of rL2PL2on plasmid-based gene therapy. In combination with previous study,
24
 we 
concluded that both types of copolymers with their architectures either reverse or similar to the 
biomembrane are effective in intramuscular gene delivery and expression. Our exploratory work 
has introduced an appealing way to design molecules that are safe, efficient and have potent 
intramuscular gene delivery capability. It also displayed the importance of structure and charge 
of the molecule for its intramuscular gene delivery function. 
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Supporting Information. 
1
H NMR spectra of G3(DMSO-d6), AE (CDCl3), AE-CDI (CDCl3), G3-PPG-G3 (DMSO-d6), 
NH2-PPG-NH2(CDCl3),DHPA (CDCl3), DHPA-NHS (CDCl3) and rL3PL3(CDCl3), and mass 
spectrumof G3. 
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